MiddleBrook Pharmaceuticals (MBRK) gapped open lower amid heavy volume but moved sideways throughout most of Wednesday's trading. The plunge came after the company announced a $100 million investment from EGI and the resignation of its President and CEO.
The stock broke support and fell below its 200-day moving average. Shares closed at their lowest level since late January, down $1.50 at $1.57.
For comments and feedback: editorial@rttnews.com